A prescription for 'stress' - the role of Hsp90 in genome stability and cellular adaptation

Trends in Cell Biology

Volumn 22, Issue 11, 2012, Pages 576-583

  Kaplan, Kenneth B ^a   Li, Rong ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptation; Cell stress; Chaperone; Genome instability; Hsp90

Indexed keywords

BRCA2 PROTEIN; DNA BINDING PROTEIN; DNA POLYMERASE; GELDANAMYCIN; GENOMIC DNA; HEAT SHOCK PROTEIN 90; MULTIPROTEIN COMPLEX; PIWI PROTEIN; PROTEASOME; PROTEOME; RAD51 PROTEIN;

CAG REPEAT; CELL CYCLE CHECKPOINT; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CENTROMERE; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; CYTOTOXICITY; DISEASE COURSE; DNA CROSS LINKING; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA SYNTHESIS; DNA TEMPLATE; DOUBLE STRANDED DNA BREAK; DOWNSTREAM PROCESSING; DROSOPHILA; FANCONI ANEMIA; GENE SILENCING; GENETIC VARIABILITY; GENOMIC INSTABILITY; GERM LINE; HETEROCHROMATIN; HUMAN; IN VIVO STUDY; INDEL MUTATION; MAMMAL CELL; MICROTUBULE; MUTAGENESIS; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN HOMEOSTASIS; QUALITY CONTROL; RECOMBINATION REPAIR; REVIEW; SEQUENCE HOMOLOGY; TRANSPOSON; WILD TYPE;

ADAPTATION, BIOLOGICAL; ANIMALS; DNA REPAIR; GENOMIC INSTABILITY; HOMEOSTASIS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; STRESS, PHYSIOLOGICAL;

EID: 84867860444     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2012.08.006     Document Type: Review

References (83)

1. Morimoto R.I. Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 2008, 22:1427-1438.
2. Sangster T.A., et al. Under cover: causes, effects and implications of Hsp90-mediated genetic capacitance. Bioessays 2004, 26:348-362.
3. Jarosz D.F., et al. Protein homeostasis and the phenotypic manifestation of genetic diversity: principles and mechanisms. Annu. Rev. Genet. 2010, 44:189-216.
4. Rutherford S.L., Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature 1998, 396:336-342.
5. Galhardo R.S., et al. Mutation as a stress response and the regulation of evolvability. Crit. Rev. Biochem. Mol. Biol. 2007, 42:399-435.
6. Specchia V., et al. Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons. Nature 2010, 463:662-665.
7. Mittelman D., et al. Hsp90 modulates CAG repeat instability in human cells. Cell Stress Chaperones 2010, 15:753-759.
8. Forche A., et al. Stress alters rates and types of loss of heterozygosity in Candida albicans. MBio 2011, 2:e00129-e211.
9. Chen G., et al. Hsp90 stress potentiates rapid cellular adaptation through induction of aneuploidy. Nature 2012, 482:246-250.
10. Makhnevych T., Houry W.A. The role of Hsp90 in protein complex assembly. Biochim. Biophys. Acta 2012, 1823:674-682.
11. Catlett M., Kaplan K. Sgt1p is a unique co-chaperone that acts as a client adaptor to link Hsp90 to Skp1p. J. Biol. Chem. 2006, 281:33739-33748.
12. Kadota Y., Shirasu K. The HSP90 complex of plants. Biochim. Biophys. Acta 2012, 1823:689-697.
13. Hunter T., Poon R.Y. Cdc37: a protein kinase chaperone?. Trends Cell Biol. 1997, 7:157-161.
14. Kimura Y., et al. Cdc37 is a molecular chaperone with specific functions in signal transduction. Genes Dev. 1997, 11:1775-1785.
15. Echtenkamp F.J., Freeman B.C. Expanding the cellular molecular chaperone network through the ubiquitous cochaperones. Biochim. Biophys. Acta 2012, 1823:668-673.
16. Friedberg E.C., et al. Trading places: how do DNA polymerases switch during translesion DNA synthesis?. Mol. Cell 2005, 18:499-505.
17. Hirota K., et al. Simultaneous disruption of two DNA polymerases, Polη and Polζ, in avian DT40 cells unmasks the role of Polη in cellular response to various DNA lesions. PLoS Genet. 2010, 6:e1001151.
18. McIntyre J., et al. The spectrum of spontaneous mutations caused by deficiency in proteasome maturase Ump1 in Saccharomyces cerevisiae. Curr. Genet. 2007, 52:221-228.
19. McIntyre J., et al. Analysis of the spontaneous mutator phenotype associated with 20S proteasome deficiency in S. cerevisiae. Mutat. Res. 2006, 593:153-163.
20. Skoneczna A., et al. Polymerase eta is a short-lived, proteasomally degraded protein that is temporarily stabilized following UV irradiation in Saccharomyces cerevisiae. J. Mol. Biol. 2007, 366:1074-1086.
21. Sekimoto T., et al. The molecular chaperone Hsp90 regulates accumulation of DNA polymerase eta at replication stalling sites in UV-irradiated cells. Mol. Cell 2010, 37:79-89.
22. Pozo F.M., et al. Molecular chaperone Hsp90 regulates REV1-mediated mutagenesis. Mol. Cell. Biol. 2011, 31:3396-3409.
23. Lawrence C.W. Cellular functions of DNA polymerase zeta and Rev1 protein. Adv. Protein Chem. 2004, 69:167-203.
24. Guo C., et al. Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. EMBO J. 2003, 22:6621-6630.
25. Tissier A., et al. Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol eta and REVl protein. DNA Repair (Amst.) 2004, 3:1503-1514.
26. Ohashi E., et al. Interaction of hREV1 with three human Y-family DNA polymerases. Genes Cells 2004, 9:523-531.
27. Kim H., et al. Regulation of Rev1 by the Fanconi anemia core complex. Nat. Struct. Mol. Biol. 2012, 19:164-170.
28. Crossan G.P., Patel K.J. The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA. J. Pathol. 2012, 226:326-337.
29. Valeri A., et al. Fanconi anaemia: from a monogenic disease to sporadic cancer. Clin. Transl. Oncol. 2011, 13:215-221.
30. Chan K., et al. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat. Cell Biol. 2009, 11:753-760.
31. Oda T., et al. Hsp90 regulates the Fanconi anemia DNA damage response pathway. Blood 2007, 109:5016-5026.
32. Mittelman D., et al. Hsp90 modulates CAG repeat instability in human cells. Cell Stress Chaperones 2010, 15:753-759.
33. Noguchi M., et al. Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Biochem. Biophys. Res. Commun. 2006, 351:658-663.
34. Arlander S.J.H., et al. Hsp90 inhibition depletes Chk1 and sensitizes tumor cells to replication stress. J. Biol. Chem. 2003, 278:52572-52577.
35. Leung-Pineda V., et al. DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res. 2009, 69:2630-2637.
36. Zhang Y.-W., et al. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell 2005, 19:607-618.
37. Enders G.H. Expanded roles for Chk1 in genome maintenance. J. Biol. Chem. 2008, 283:17749-17752.
38. Hurst G.D., Werren J.H. The role of selfish genetic elements in eukaryotic evolution. Nat. Rev. Genet. 2001, 2:597-606.
39. Juliano C., et al. Uniting germline and stem cells: the function of Piwi proteins and the piRNA pathway in diverse organisms. Annu. Rev. Genet. 2011, 45:447-469.
40. Sollars V., et al. Evidence for an epigenetic mechanism by which Hsp90 acts as a capacitor for morphological evolution. Nat. Genet. 2003, 33:70-74.
41. Gangaraju V.K., et al. Drosophila Piwi functions in Hsp90-mediated suppression of phenotypic variation. Nat. Genet. 2011, 43:153-158.
42. Kakihara Y., Houry W.A. The R2TP complex: discovery and functions. Biochim. Biophys. Acta 2012, 1823:101-107.
43. Lechner J., Carbon J. A 240 kd multisubunit protein complex, CBF3, is a major component of the budding yeast centromere. Cell 1991, 64:717-725.
44. McAinsh A.D., et al. Structure, function, and regulation of budding yeast kinetochores. Annu. Rev. Cell Dev. Biol. 2003, 19:519-539.
45. Kaplan K.B., et al. Regulating the yeast kinetochore by ubiquitin-dependent degradation and Skp1p-mediated phosphorylation. Cell 1997, 91:491-500.
46. Rodrigo-Brenni M.C., et al. Sgt1p and Skp1p modulate the assembly and turnover of CBF3 complexes required for proper kinetochore function. Mol. Biol. Cell 2004, 15:3366-3378.
47. Stemmann O., et al. Hsp90 enables Ctf13p/Skp1p to nucleate the budding yeast kinetochore. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8585-8590.
48. Kitagawa K., et al. SGT1 encodes an essential component of the yeast kinetochore assembly pathway and a novel subunit of the SCF ubiquitin ligase complex. Mol. Cell 1999, 4:21-33.
49. Lingelbach L., Kaplan K. The interaction between Sgt1p and Skp1p is regulated by HSP90 chaperones and is required for proper CBF3 assembly. Mol. Cell. Biol. 2004, 24:8938-8950.
50. Deshaies R.J. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 1999, 15:435-467.
51. Feldman R.M., et al. A complex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 1997, 91:221-230.
52. Thomas S., Kaplan K.B. A Bir1p Sli15p kinetochore passenger complex regulates septin organization during anaphase. Mol. Biol. Cell 2007, 18:3820-3834.
53. Gillis A., et al. A novel role for the CBF3 kinetochore-scaffold complex in regulating septin dynamics and cytokinesis. J. Cell Biol. 2005, 171:773-784.
54. Rozelle D.K., et al. Chromosome passenger complexes control anaphase duration and spindle elongation via a kinesin-5 brake. J. Cell Biol. 2011, 193:285-294.
55. Wan X., et al. Protein architecture of the human kinetochore microtubule attachment site. Cell 2009, 137:672-684.
56. Cheeseman I., et al. The conserved KMN network constitutes the core microtubule-binding site of the kinetochore. Cell 2006, 127:983-997.
57. Davies A.E., Kaplan K.B. Hsp90-Sgt1 and Skp1 target human Mis12 complexes to ensure efficient formation of kinetochore-microtubule binding sites. J. Cell Biol. 2010, 189:261-274.
58. Rossio V., et al. Adapt or die: how eukaryotic cells respond to prolonged activation of the spindle assembly checkpoint. Biochem. Soc. Trans. 2010, 38:1645-1649.
59. Janssen A., et al. Chromosome segregation errors as a cause of DNA damage and structural chromosome aberrations. Science 2011, 333:1895-1898.
60. Crasta K., et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 2012, 482:53-58.
61. Gordon D.J., et al. Causes and consequences of aneuploidy in cancer. Nat. Rev. Genet. 2012, 13:189-203.
62. Iourov I.Y., et al. Somatic genome variations in health and disease. Curr. Genomics 2010, 11:387-396.
63. Pavelka N., et al. Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer. Curr. Opin. Cell Biol. 2010, 22:809-815.
64. Upender M.B., et al. Chromosome transfer induced aneuploidy results in complex dysregulation of the cellular transcriptome in immortalized and cancer cells. Cancer Res. 2004, 64:6941-6949.
65. Gao C., et al. Chromosome instability, chromosome transcriptome, and clonal evolution of tumor cell populations. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:8995-9000.
66. Hughes T.R., et al. Widespread aneuploidy revealed by DNA microarray expression profiling. Nat. Genet. 2000, 25:333-337.
67. Birchler J.A. Reflections on studies of gene expression in aneuploids. Biochem. J. 2010, 426:119-123.
68. Pavelka N., et al. Aneuploidy confers quantitative proteome changes and phenotypic variation in budding yeast. Nature 2010, 468:321-325.
69. Springer M., et al. A general lack of compensation for gene dosage in yeast. Mol. Syst. Biol. 2010, 6:368.
70. Torres E.M., et al. Identification of aneuploidy-tolerating mutations. Cell 2010, 143:71-83.
71. Rancati G., et al. Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell 2008, 135:879-893.
72. Selmecki A., et al. Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science 2006, 313:367-370.
73. Selmecki A.M., et al. Acquisition of aneuploidy provides increased fitness during the evolution of antifungal drug resistance. PLoS Genet. 2009, 5:e1000705.
74. Sionov E., et al. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes. PLoS Pathog. 2010, 6:e1000848.
75. Semighini C.P., et al. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner. PLoS Pathog. 2011, 7:e1002364.
76. Gupta R.K., Srinivas U.K. Heat shock induces chromosomal instability in near-tetraploid embryonal carcinoma cells. Cancer Biol. Ther. 2008, 7:1471-1480.
77. Kamal A., et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature 2003, 425:407-410.
78. Mollapour M., Neckers L. Post-translational modifications of Hsp90 and their contributions to chaperone regulation. Biochim. Biophys. Acta 2012, 1823:648-655.
79. Miyata Y., Nishida E. CK2 controls multiple protein kinases by phosphorylating a kinase-targeting molecular chaperone, Cdc37. Mol. Cell. Biol. 2004, 24:4065-4074.
80. Bansal P.K., et al. Sgt1 dimerization is negatively regulated by protein kinase CK2-mediated phosphorylation at Ser361. J. Biol. Chem. 2009, 284:18692-18698.
81. Cowen L.E., Lindquist S. Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 2005, 309:2185-2189.
82. Jhaveri K., et al. Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers. Biochim. Biophys. Acta 2012, 1823:742-755.
83. Frankland-Searby S., Bhaumik S.R. The 26S proteasome complex: an attractive target for cancer therapy. Biochim. Biophys. Acta 2012, 1825:64-76.